Skip to main content
Caplight Logo









Everest Biolabs

Everest Biolabs

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://everestbiolabs.com/

Last Round

Seed

Mar 11, 2026

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Everest Biolabs is a life sciences company that provides automated instruments and assay kits for extracellular vesicle and exosome isolation and analytics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

extracellular vesicle isolationexosome researchEV isolationlaboratory automationsize-exclusion chromatographySECbiomarker discoveryELISA kitshigh-throughput screeningwet lab automationbiotech equipmentclinical diagnosticsbenchtop instrumentslife sciences toolsliquid handling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Everest Biolabs Comparables

Compare Everest Biolabs with similar companies based on industry and business-model similarity.

Everest Biolabs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exodus Bio
84%
Cell Guidance Systems
82%
LabSpinner
79%

Everest Biolabs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 11, 2026

Key People

Founding team and executive leadership

David Freedman

COO, President, and Founder

Founding Team

George Daaboul

CEO and co-founder

Founding Team

Everest Biolabs Investors

Notable investors and investment history

Everest Biolabs investors
InvestorRounds
MassVenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 97% MoM.

  • Jun 25, 2026

    Monthly visitors increased 109% MoM, reaching 2.2K.

Recent news

Latest coverage and updates

  • is_developingSep 25, 2026

    Everest Biolabs is developing automated, plate-based tools for isolating extracellular vesicles from plasma on Sep 1st '26.

  • receives_financingSep 25, 2026

    Everest Biolabs received financing of $2.1M in Small Business Innovation Research grant on Sep 1st '26.

Everest Biolabs Filings

Explore SEC and related filing metadata, where available.

Everest Biolabs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Everest Biolabs's valuation, stock price, and market status.

Is Everest Biolabs a public or private company?

Everest Biolabs is a private company.

What is the current stock price of Everest Biolabs?

Everest Biolabs is a private company with no public stock price. No recent secondary market data is available.

How much is Everest Biolabs worth (valuation)?

Valuation information for Everest Biolabs is not publicly available.

Can I buy Everest Biolabs stock?

Everest Biolabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Everest Biolabs's last funding round?

Everest Biolabs's most recent funding round was Seed Round on March 11, 2026.

Who are the main investors in Everest Biolabs?

Investor information for Everest Biolabs is not publicly disclosed.

Will Everest Biolabs IPO soon?

No public IPO plans have been announced for Everest Biolabs.

How can I track Everest Biolabs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Everest Biolabs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range9
Year Founded2024
Last FundingMar 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?